Citadel Advisors
AGL icon

Citadel Advisors’s Agilon Health AGL Stock Holding History

Citadel Advisors’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.57M Buy
70,628
+60,072
+569% +$3.93M ﹤0.01% 4022
2026
Q1 		$83.5K Buy
10,556
+2,336
+28% +$37.8K ﹤0.01% 12150
2025
Q4 		$142K Sell
8,220
-5,932
-42% -$115K ﹤0.01% 11366
2025
Q3 		$364K Sell
14,152
-6,792
-32% -$257K ﹤0.01% 9892
2025
Q2 		$1.2M Buy
20,944
+7,580
+57% +$608K ﹤0.01% 6690
2025
Q1 		$1.45M Sell
13,364
-7,392
-36% -$643K ﹤0.01% 6164
2024
Q4 		$986K Sell
20,756
-64
-0.3% -$3.87K ﹤0.01% 7051
2024
Q3 		$2.05M Buy
20,820
+6,932
+50% +$895K ﹤0.01% 5486
2024
Q2 		$2.27M Buy
13,888
+5,680
+69% +$809K ﹤0.01% 5075
2024
Q1 		$1.25M Buy
8,208
+2,016
+33% +$335K ﹤0.01% 6471
2023
Q4 		$1.94M Buy
6,192
+344
+6% +$125K ﹤0.01% 5406
2023
Q3 		$2.6M Buy
5,848
+460
+9% +$208K ﹤0.01% 4749
2023
Q2 		$2.34M Sell
5,388
-688
-11% -$387K ﹤0.01% 4888
2023
Q1 		$3.61M Sell
6,076
-1,588
-21% -$889K ﹤0.01% 4351
2022
Q4 		$3.09M Buy
7,664
+2,204
+40% +$1.03M ﹤0.01% 4707
2022
Q3 		$3.2M Buy
5,460
+3,724
+215% +$2.23M ﹤0.01% 4679
2022
Q2 		$947K Sell
1,736
-292
-14% -$148K ﹤0.01% 7141
2022
Q1 		$1.28M Buy
2,028
+740
+57% +$381K ﹤0.01% 7115
2021
Q4 		$869K Buy
+1,288
New +$784K ﹤0.01% 8294
2021
Q3 		– Sell
-392
Closed -$398K – 13728
2021
Q2 		$398K Buy
+392
New +$343K ﹤0.01% 10570

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Citadel Advisors's AGL Position: Q2 2026 in Review

Citadel Advisors opened a new position in Agilon Health (AGL) in Q2 2026: 56,045 shares worth $6.01M. The stake represents ﹤0.01% of the portfolio and ranks #4415 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in AGL as recently as Q4 2025.

Citadel Advisors first reported a position in AGL in Q2 2021 and has held it in 17 quarters since. The position peaked at $35.1M in Q2 2021. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Citadel Advisors held 56,045 shares of Agilon Health worth $6.01M as of Q2 2026.
  • Agilon Health was a new Citadel Advisors position in Q2 2026.
  • Agilon Health made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #4415 holding.
  • Citadel Advisors first reported a position in Agilon Health in Q2 2021 and has held it in 17 quarters since.
  • Citadel Advisors's Agilon Health position peaked at $35.1M in Q2 2021.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.